Nevanimibe HCl for the Treatment of Classic CAH

Clinical trial NCT03669549 · TERMINATED

Trial details

NCT number: NCT03669549
Sponsor: Millendo Therapeutics US, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia

Start date: 2018-07-11
Primary completion: 2020-06-03
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.